• Mar 02, 2025

2 Reasons to Avoid PAYX and 1 Stock to Buy Instead

Paychex has had an impressive run over the past six months as its shares have beaten the S&P 500 by 6.6%. The stock now trades at $150.71, marking a 14.2% gain. This performance may have investors wondering how to approach the situation.

  • Mar 02, 2025

3 Reasons to Sell CSL and 1 Stock to Buy Instead

Over the past six months, Carlisle’s stock price fell to $343.26. Shareholders have lost 14.9% of their capital, which is disappointing considering the S&P 500 has climbed by 7.6%. This was partly driven by its softer quarterly results and might have investors contemplating their next move.

  • Mar 02, 2025

3 Reasons BIIB is Risky and 1 Stock to Buy Instead

Shareholders of Biogen would probably like to forget the past six months even happened. The stock dropped 31.4% and now trades at $140.49. This was partly driven by its softer quarterly results and might have investors contemplating their next move.